Metabolic effects of second-generation antipsychotics: meta-analysis


UPDATE ON SCHIZOPHRENIA – Some second-generation antipsychotic medications are associated with substantially more metabolic side effects than other SGAs, according to a Cochrane analysis of 48 studies of schizophrenia (Rummel-Kluge et al. Schizophr Res 2010; 123: 225-233).


It takes 30 seconds

Recommend to a Colleague

Related Posts

Go back to home page